Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

USA - NASDAQ:OLPX - US6793691089 - Common Stock

1.42 USD
-0.02 (-1.39%)
Last: 9/12/2025, 8:06:00 PM
1.42 USD
0 (0%)
After Hours: 9/12/2025, 8:06:00 PM
Fundamental Rating

5

Overall OLPX gets a fundamental rating of 5 out of 10. We evaluated OLPX against 36 industry peers in the Personal Care Products industry. OLPX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. OLPX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year OLPX was profitable.
In the past year OLPX had a positive cash flow from operations.
In the past 5 years OLPX has always been profitable.
In the past 5 years OLPX always reported a positive cash flow from operatings.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.08%, OLPX is in line with its industry, outperforming 44.44% of the companies in the same industry.
With a Return On Equity value of -0.15%, OLPX perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
With a Return On Invested Capital value of 2.54%, OLPX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for OLPX is below the industry average of 12.91%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROIC 2.54%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

OLPX's Profit Margin has declined in the last couple of years.
OLPX's Operating Margin of 10.97% is fine compared to the rest of the industry. OLPX outperforms 72.22% of its industry peers.
In the last couple of years the Operating Margin of OLPX has declined.
With a decent Gross Margin value of 70.81%, OLPX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
OLPX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.97%
PM (TTM) N/A
GM 70.81%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), OLPX is creating some value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
OLPX has more shares outstanding than it did 5 years ago.
OLPX has a better debt/assets ratio than last year.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.04 indicates that OLPX is not a great score, but indicates only limited risk for bankruptcy at the moment.
OLPX's Altman-Z score of 2.04 is in line compared to the rest of the industry. OLPX outperforms 41.67% of its industry peers.
OLPX has a debt to FCF ratio of 3.63. This is a good value and a sign of high solvency as OLPX would need 3.63 years to pay back of all of its debts.
OLPX's Debt to FCF ratio of 3.63 is fine compared to the rest of the industry. OLPX outperforms 77.78% of its industry peers.
OLPX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
OLPX has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: OLPX outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Altman-Z 2.04
ROIC/WACC0.32
WACC8.01%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 3.86. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.86, OLPX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
OLPX has a Quick Ratio of 3.20. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a better Quick ratio (3.20) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.2
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

OLPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
OLPX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.10% yearly.
The Revenue has decreased by -3.44% in the past year.
OLPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%

3.2 Future

Based on estimates for the next years, OLPX will show a decrease in Earnings Per Share. The EPS will decrease by -4.14% on average per year.
The Revenue is expected to grow by 29.95% on average over the next years. This is a very strong growth
EPS Next Y-44.36%
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue Next Year2.64%
Revenue Next 2Y2.87%
Revenue Next 3Y2.9%
Revenue Next 5Y29.95%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.75, OLPX is valued on the expensive side.
OLPX's Price/Earnings ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 75.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of OLPX to the average of the S&P500 Index (27.30), we can say OLPX is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.52, which indicates a correct valuation of OLPX.
OLPX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 72.22% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. OLPX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.75
Fwd PE 16.52
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

OLPX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 72.22% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.76
EV/EBITDA 10.26
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

OLPX's earnings are expected to decrease with -4.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%

0

5. Dividend

5.1 Amount

No dividends for OLPX!.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (9/12/2025, 8:06:00 PM)

After market: 1.42 0 (0%)

1.42

-0.02 (-1.39%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners13.9%
Inst Owner Change0.01%
Ins Owners0.5%
Ins Owner Change39.79%
Market Cap947.25M
Analysts52.86
Price Target2.1 (47.89%)
Short Float %7.87%
Short Ratio8.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.18%
Min EPS beat(2)-32.11%
Max EPS beat(2)60.46%
EPS beat(4)2
Avg EPS beat(4)22%
Min EPS beat(4)-32.11%
Max EPS beat(4)69.03%
EPS beat(8)5
Avg EPS beat(8)16.36%
EPS beat(12)8
Avg EPS beat(12)10.16%
EPS beat(16)12
Avg EPS beat(16)10.46%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.35%
Max Revenue beat(2)3.89%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)6
Avg Revenue beat(8)1.96%
Revenue beat(12)7
Avg Revenue beat(12)-0.92%
Revenue beat(16)11
Avg Revenue beat(16)0.66%
PT rev (1m)-1.03%
PT rev (3m)-0.35%
EPS NQ rev (1m)-7.5%
EPS NQ rev (3m)-42.89%
EPS NY rev (1m)-8.48%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)-7.65%
Revenue NQ rev (3m)-7.92%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 17.75
Fwd PE 16.52
P/S 2.24
P/FCF 9.76
P/OCF 9.37
P/B 1.08
P/tB N/A
EV/EBITDA 10.26
EPS(TTM)0.08
EY5.63%
EPS(NY)0.09
Fwd EY6.05%
FCF(TTM)0.15
FCFY10.25%
OCF(TTM)0.15
OCFY10.67%
SpS0.63
BVpS1.31
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROCE 3.32%
ROIC 2.54%
ROICexc 3.2%
ROICexgc 54.14%
OM 10.97%
PM (TTM) N/A
GM 70.81%
FCFM 22.94%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Debt/EBITDA 3.53
Cap/Depr 7.58%
Cap/Sales 0.95%
Interest Coverage 0.85
Cash Conversion 101.42%
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.2
Altman-Z 2.04
F-Score5
WACC8.01%
ROIC/WACC0.32
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
EPS Next Y-44.36%
EPS Next 2Y-11.59%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%
Revenue Next Year2.64%
Revenue Next 2Y2.87%
Revenue Next 3Y2.9%
Revenue Next 5Y29.95%
EBIT growth 1Y-49.69%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-15.89%
EBIT Next 3Y-2.97%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-50.02%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%